Item 2.02. Results of Operations and Financial Condition.

On August 14, 2012, NewLink Genetics Corporation, a Delaware corporation (the "Company"), issued a press release reporting financial results for the second quarter ended June 30, 2012.

The press release is attached hereto as Exhibit 99.1, which is furnished under Item 2.02 of this report and shall not be deemed to be "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, regardless of any general incorporation language in such filing.

---